Catheter Precision (VTAK) announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, executed on March 9. The March 9th transaction establishes Flyte as a wholly owned operating subsidiary. With full ownership complete: 100% of Flyte’s revenue and operations are now consolidated into VTAK; Direct exposure to operating performance and cash flow; Full control of capital allocation, fleet expansion, and growth strategy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Shareholders Approve Reverse Split, Capital Changes
- Catheter Precision engages advisor to sell cardiac electrophysiology business
- Catheter Precision announces launch of Flyte Hops Florida
- Catheter Precision secures up to $88M in institutional financing commitments
- Morning News Wrap-Up 3/10/26: Tuesday’s Biggest Stock Market Stories!